| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.05 |